These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22922018)

  • 1. Epitope mapping of botulinum neurotoxins light chains.
    Zdanovsky A; Zdanovsky D; Zdanovskaia M
    Toxicon; 2012 Dec; 60(7):1277-86. PubMed ID: 22922018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).
    Scotcher MC; McGarvey JA; Johnson EA; Stanker LH
    PLoS One; 2009; 4(3):e4924. PubMed ID: 19290051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
    Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
    J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant proteins that trigger production of antibodies recognizing botulinum neurotoxin while not possessing sequences of this toxin.
    Zdanovsky A; Zdanovskaia M
    Toxicon; 2013 Jun; 67():63-70. PubMed ID: 23499926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the regions on the C-terminal domain of the heavy chain of botulinum A recognized by T lymphocytes and by antibodies after immunization of mice with pentavalent toxoid.
    Rosenberg JS; Middlebrook JL; Atassi MZ
    Immunol Invest; 1997 Jun; 26(4):491-504. PubMed ID: 9246568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
    Smith TJ; Lou J; Geren IN; Forsyth CM; Tsai R; Laporte SL; Tepp WH; Bradshaw M; Johnson EA; Smith LA; Marks JD
    Infect Immun; 2005 Sep; 73(9):5450-7. PubMed ID: 16113261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope characterization of sero-specific monoclonal antibody to Clostridium botulinum neurotoxin type A.
    Corbett CR; Ballegeer E; Weedmark KA; Elias MD; Al-Saleem FH; Ancharski DM; Simpson LL; Berry JD
    Hybridoma (Larchmt); 2011 Dec; 30(6):503-10. PubMed ID: 22149274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.
    Chen C; Wang S; Wang H; Mao X; Zhang T; Ji G; Shi X; Xia T; Lu W; Zhang D; Dai J; Guo Y
    PLoS One; 2012; 7(8):e43845. PubMed ID: 22952786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains.
    Atassi MZ; Oshima M; Dolimbek BZ; Aoki KR
    Immunobiology; 2012 Jan; 217(1):1-7. PubMed ID: 22015045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.
    Yu R; Wang S; Yu YZ; Du WS; Yang F; Yu WY; Sun ZW
    J Biomol Screen; 2009 Sep; 14(8):991-8. PubMed ID: 19726786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the epitope region of F1-2 and F1-5, two monoclonal antibodies to Botulinum neurotoxin type A.
    Scotcher MC; Johnson EA; Stanker LH
    Hybridoma (Larchmt); 2009 Oct; 28(5):315-25. PubMed ID: 19857112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
    Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
    Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.
    Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
    PLoS One; 2010 Aug; 5(8):e12237. PubMed ID: 20808925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
    Atassi MZ; Jankovic J; Steward LE; Aoki KR; Dolimbek BZ
    Immunobiology; 2012 Jan; 217(1):17-27. PubMed ID: 21962573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune recognition of botulinum neurotoxin type A: regions recognized by T cells and antibodies against the protective H(C) fragment (residues 855-1296) of the toxin.
    Oshima M; Hayakari M; Middlebrook JL; Atassi MZ
    Mol Immunol; 1997 Oct; 34(14):1031-40. PubMed ID: 9488054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.
    Li B; Cardinale SC; Butler MM; Pai R; Nuss JE; Peet NP; Bavari S; Bowlin TL
    Bioorg Med Chem; 2011 Dec; 19(24):7338-48. PubMed ID: 22082667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum.
    Dertzbaugh MT; West MW
    Vaccine; 1996 Nov; 14(16):1538-44. PubMed ID: 9014296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR; Rees J; Liu SM; Acharya KR
    J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological characterization of the subunits of type A botulinum neurotoxin and different components of its associated proteins.
    Kukreja R; Chang TW; Cai S; Lindo P; Riding S; Zhou Y; Ravichandran E; Singh BR
    Toxicon; 2009 May; 53(6):616-24. PubMed ID: 19673075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.
    Atassi MZ; Dolimbek BZ; Hayakari M; Middlebrook JL; Whitney B; Oshima M
    J Protein Chem; 1996 Oct; 15(7):691-700. PubMed ID: 8968960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.